This secondary analysis reports the survival outcome in patients with EGFR variant-positive non–small-cell lung cancer who had a body mass index that was higher or lower than 24.
No takes yet. Share an insight, caveat, or question.
Arrieta et al. (2022) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: